Literature DB >> 10807983

Role of antioxidant enzymes in brain tumours.

G M Rao1, A V Rao, A Raja, S Rao, A Rao.   

Abstract

Erythrocyte antioxidant enzymes were analysed in 100 patients with intracranial neoplasm and in 47 controls. There was a significant decrease in RBC glutathione reductase (GRx) and superoxide dismutase (SOD) activity in most types of brain tumor cases. Patients with acoustic neurinoma showed a significant reduction in selenium-dependent glutathione peroxidase (Se-GPx) activity. A decrease in catalase (CT) activity was seen in most of the brain tumor patients but remained statistically insignificant when compared to controls. A significant increase in plasma ceruloplasmin concentration was observed in patients with glioma. These enzymes were also studied in 27 post-treatment cases. GRx activity returned to normal levels in these patients. RBC SOD and plasma ceruloplasmin levels showed a tendency to return to normal. Hence, a marked decrease in the antioxidant enzymes may have a role in the genesis of considerable oxidative stress in patients with brain tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807983     DOI: 10.1016/s0009-8981(00)00219-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Susceptibility of peripheral lymphocytes of brain tumour patients to in vitro radiation-induced DNA damage, a preliminary study.

Authors:  Guruprasad Kalthur; Prem Kumar; Uma Devi; Sabir Ali; Ramya Upadhya; Sailaja Pillai; Anjali Rao
Journal:  Clin Exp Med       Date:  2008-09-13       Impact factor: 3.984

2.  Multi-element Analysis of Brain Regions from South African Cadavers.

Authors:  Karen Cilliers; Christo J F Muller
Journal:  Biol Trace Elem Res       Date:  2020-05-02       Impact factor: 3.738

3.  Glutathione peroxidase, glutathione reductase and protein oxidation in patients with glioblastoma multiforme and transitional meningioma.

Authors:  Taner Tanriverdi; Hakan Hanimoglu; Tibet Kacira; Galip Zihni Sanus; Rahsan Kemerdere; Pinar Atukeren; Koray Gumustas; Bulent Canbaz; Mehmet Yasar Kaynar
Journal:  J Cancer Res Clin Oncol       Date:  2007-04-25       Impact factor: 4.553

4.  Oxidative response gene polymorphisms and risk of adult brain tumors.

Authors:  Preetha Rajaraman; Amy Hutchinson; Nathaniel Rothman; Peter M Black; Howard A Fine; Jay S Loeffler; Robert G Selker; William R Shapiro; Martha S Linet; Peter D Inskip
Journal:  Neuro Oncol       Date:  2008-08-05       Impact factor: 12.300

5.  Comparative analysis of antioxidative systems in malignant and benign brain tumours.

Authors:  Vojislav Bogosavljević; Milica Bajčetić; Ivan Spasojević
Journal:  Redox Rep       Date:  2014-09-23       Impact factor: 4.412

6.  Differential suitability of reactive oxygen species and the role of glutathione in regulating paradoxical behavior in gliomas: A mathematical perspective.

Authors:  Rupa Bhowmick; Ram Rup Sarkar
Journal:  PLoS One       Date:  2020-06-25       Impact factor: 3.240

7.  The SP/NK1R System-Mediated ROS Generation in GBM Cells through Inhibiting Glutaredoxin Protein.

Authors:  Negeen Mehrabani; Mohammad Reza Vaezi Kakhki; Hossein Javid; Safieh Ebrahimi; Seyed Isaac Hashemy
Journal:  Neurol Res Int       Date:  2021-12-07

8.  Parameters of antioxidant barrier in different histopathologic types of pediatric cancers.

Authors:  Teresa Stachowicz-Stencel; Anna Synakiewicz; Anna Owczarzak; Aleksandra Sliwinska; Wieslawa Lysiak-Szydlowska; Anna Balcerska
Journal:  Contemp Oncol (Pozn)       Date:  2012-05-29

9.  Pathogenic role of the SP/ NK1R system in GBM cells through inhibiting the thioredoxin system.

Authors:  Fatemeh Ghahremani; Reihaneh Sabbaghzadeh; Safieh Ebrahimi; Hosein Javid; Javad Ghahremani; Seyed Isaac Hashemy
Journal:  Iran J Basic Med Sci       Date:  2021-04       Impact factor: 2.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.